Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent subcutaneous apomorphine for non-motor symptoms in Parkinson's disease
2010-019198-14Phase 4Active
- Sponsor
- Karolinska University Hospital
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of apomorphine in Parkinson's disease (PD), sponsored by Karolinska University Hospital. Primary endpoints: Pilot feasibility and signal detection for non-motor effects, Non-motor symptom relief and 1 more. Started Sep 2010; status: active.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2010-019198-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019198-14.